Drug Type Small molecule drug |
Synonyms Fipamezole |
Target |
Mechanism ADRA2 antagonists(Adrenergic receptors alpha-2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC14H16ClFN2 |
InChIKeyXAGTWPPXXHAZMK-UHFFFAOYSA-N |
CAS Registry150586-72-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypotension orthostatic symptomatic | Phase 2 | FR | 01 Sep 2008 | |
Hypotension orthostatic symptomatic | Phase 2 | PT | 01 Sep 2008 | |
Neurogenic Orthostatic Hypotension | Phase 2 | PT | 01 Sep 2008 | |
Parkinson Disease | Phase 2 | US | - | |
Parkinson Disease | Phase 2 | IN | - | |
Tardive Dyskinesia | Phase 2 | - | - | |
Tardive Dyskinesia | Phase 2 | - | - | |
Neurogenic Orthostatic Hypotension | Discovery | FR | 01 Sep 2008 | |
Neurogenic Orthostatic Hypotension | Discovery | FR | 01 Sep 2008 | |
Neurogenic Orthostatic Hypotension | Discovery | PT | 01 Sep 2008 |